Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
25066 | 243 | 28.7 | 58% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
202 | 20434 | CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VESSEL WALL INJURY | Author keyword | 5 | 60% | 2% | 6 |
2 | INTERDISCIPLINARY EXCELLENCE PROGRAM HLTH AGI | Address | 5 | 38% | 4% | 10 |
3 | CLIN BIOCHEM IMMUNOHEMATOL | Address | 5 | 30% | 5% | 13 |
4 | ENGN BIOINFORMAT | Address | 3 | 60% | 1% | 3 |
5 | MED CORP JINKEIKAI | Address | 2 | 67% | 1% | 2 |
6 | NON ANTICOAGULATED BLOOD | Author keyword | 2 | 67% | 1% | 2 |
7 | NATURAL ANTIPLATELET AGENTS | Author keyword | 1 | 100% | 1% | 2 |
8 | SINTESIS | Address | 1 | 100% | 1% | 2 |
9 | THROMBOEMBOLISM PATHOPHYSIOLOGY | Author keyword | 1 | 100% | 1% | 2 |
10 | MED CARE LINE | Address | 1 | 30% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | THROMBOSIS TEST | 6 | 80% | 2% | 4 |
2 | SPONTANEOUS THROMBOLYTIC ACTIVITY | 4 | 67% | 2% | 4 |
3 | PRISM GRATING SYSTEM | 4 | 75% | 1% | 3 |
4 | NATIVE BLOOD | 4 | 29% | 5% | 12 |
5 | PLATELET THROMBI | 3 | 100% | 1% | 3 |
6 | INDUCED PROTHROMBOTIC STATE | 1 | 100% | 1% | 2 |
7 | PROSTAGLANDIN E1 PROSTACYCLIN | 1 | 40% | 1% | 2 |
8 | SHRSP | 1 | 17% | 2% | 5 |
9 | KOREAN TRADITIONAL FORMULATION | 1 | 50% | 0% | 1 |
10 | PLATELET HYPERREACTIVITY | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Microvascular thrombosis models in venules and arterioles in vivo | 2005 | 42 | 89 | 20% |
Antiplatelet effects of natural bioactive compounds by multiple targets: Food and drug interactions | 2014 | 5 | 115 | 7% |
Shear-induced in-vitro haemostasis/thrombosis tests: the benefit of using native blood | 2003 | 7 | 55 | 22% |
Relationship between Platelet PPARs, cAMP Levels, and P-Selectin Expression: Antiplatelet Activity of Natural Products | 2013 | 2 | 119 | 8% |
Regulation of microvascular thromboembolism in vivo | 2005 | 17 | 110 | 8% |
HYPOXIC REDUCTION IN BLOOD-FLOW VELOCITY IN PULMONARY ARTERIOLES AND CAPILLARIES | 1984 | 1 | 1 | 100% |
CESSATION OF CAPILLARY BLOOD-FLOW INDUCED BY LOCALIZED APPLICATION OF CARBON-DIOXIDE | 1984 | 0 | 1 | 100% |
Dietary components and human platelet activity | 2002 | 35 | 73 | 1% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTERDISCIPLINARY EXCELLENCE PROGRAM HLTH AGI | 5 | 38% | 4.1% | 10 |
2 | CLIN BIOCHEM IMMUNOHEMATOL | 5 | 30% | 5.3% | 13 |
3 | ENGN BIOINFORMAT | 3 | 60% | 1.2% | 3 |
4 | MED CORP JINKEIKAI | 2 | 67% | 0.8% | 2 |
5 | SINTESIS | 1 | 100% | 0.8% | 2 |
6 | MED CARE LINE | 1 | 30% | 1.2% | 3 |
7 | PIEI ES | 1 | 33% | 0.8% | 2 |
8 | CARDIOVASC CLIN TRIALS | 1 | 50% | 0.4% | 1 |
9 | FOOD IND CONVERGENCE | 1 | 50% | 0.4% | 1 |
10 | PIFRECV | 1 | 50% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000104020 | PLATELET PMN INTERACTION//ATHLETIC HORSE//B TG |
2 | 0.0000101722 | SPONTANEOUS PLATELET AGGREGATION//PARTICLE COUNTING METHOD//AGGREGOMETER |
3 | 0.0000101711 | DERMCIDIN ISOFORM 2//ACUTE ISCHEMIC HEART DISEASE//GEA 3175 |
4 | 0.0000092187 | FIBRINOGEN THROMBIN CLOTTING//FIBRIN ALPHA CHAIN//COLLAGEN RELATED SYNTHETIC PEPTIDE |
5 | 0.0000083165 | CORONARY ARTERIAL TONE//VASC BIOL MED ERFURT//PLATELET NEUTROPHIL INTERACTION |
6 | 0.0000078580 | ASPIRIN RESISTANCE//PFA 100//THROMBOSTAT |
7 | 0.0000076301 | NAFTIDROFURYL//NEBRACETAM//MICROSPHERE EMBOLISM |
8 | 0.0000074265 | IBUDILAST//CAS 50847 11 5//221 MIYAMA |
9 | 0.0000067155 | GLYCOPROTEIN VI//GPVI//CLEC 2 |
10 | 0.0000066572 | ENDOTHELAEMIA//INTERDISCIPLINARY ONCOLEXPT THER EUT PROGR//ENDOTHELEMIA |